Reason: CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.
Distributed: Florida, Illinois, Iowa, New JerseyReason: CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.
Distributed: Florida, Illinois, Iowa, New JerseyReason: CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.
Distributed: Florida, Illinois, Iowa, New JerseyReason: cGMP Deviations: deviations leading to potential cross-contamination.
Distributed: USA NationwideReason: Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.
Distributed: Product was distributed to 6 distributors/wholesalers who may have further distributed the product.Reason: Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.
Distributed: Product was distributed to 6 distributors/wholesalers who may have further distributed the product.Reason: Failed Impurities/Degradation Specifications
Distributed: Nationwide.Reason: Subpotent Drug
Distributed: Nationwide within the USAReason: Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.
Distributed: Nationwide in the USAReason: CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Distributed: Nationwide in the USA